HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is Hypospadias Associated with Prenatal Exposure to Endocrine Disruptors? A French Collaborative Controlled Study of a Cohort of 300 Consecutive Children Without Genetic Defect.

AbstractBACKGROUND:
Numerous studies have focused on the association between endocrine-disrupting chemicals (EDCs) and hypospadias. Phenotype variability, the absence of representative comparison groups and concomitant genetic testing prevent any definitive conclusions.
OBJECTIVE:
To identify the role of occupational and environmental exposures to EDCs in nongenetic isolated hypospadias.
DESIGN, SETTING, AND PARTICIPANTS:
A total of 408 consecutive children with isolated hypospadias and 302 normal boys were prospectively included (2009-2014) in a multi-institutional study in the south of France, the area of the country with the highest prevalence of hypospadias surgery.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:
In patients without AR, SRD5A2, and MAMLD1 mutations, parental occupational and professional exposures to EDCs were evaluated based on European questionnaire QLK4-1999-01422 and a validated job-exposure matrix for EDCs. Environmental exposure was estimated using the zip code, the type of surrounding hazards, and distance from these hazards. Multivariate analysis was performed.
RESULTS:
Fetal exposure to EDCs around the window of genital differentiation was more frequent in the case of hypospadias (40.00% vs 17.55%, odds ratio 3.13, 95% confidence interval 2.11-4.65). The substances were paints/solvents/adhesives (16.0%), detergents (11.0%), pesticides (9.0%), cosmetics (5.6%), and industrial chemicals (4.0%). Jobs with exposure were more frequent in mothers of hypospadiac boys (19.73% vs 10.26%, p=0.0019), especially cleaners, hairdressers, beauticians, and laboratory workers. Paternal job exposure was more frequent in the cases of hypospadias (40.13% vs 27.48%, p=0.02). Industrial areas, incinerators, and waste areas were more frequent within a 3-km radius for mothers of hypospadiac boys (13.29% vs. 6.64%, p<0.00005). Association of occupational and environmental exposures increases this risk.
CONCLUSIONS:
This multicenter prospective controlled study with a homogeneous cohort of hypospadiac boys without genetic defects strongly suggests that EDCs are a risk factor for hypospadias through occupational and environmental exposure during fetal life. The association of various types of exposures may increase this risk.
PATIENT SUMMARY:
Our multi-institutional study showed that parental professional, occupational, and environmental exposures to chemical products increase the risk of hypospadias in children.
AuthorsNicolas Kalfa, Françoise Paris, Pascal Philibert, Mattea Orsini, Sylvie Broussous, Nadège Fauconnet-Servant, Françoise Audran, Laura Gaspari, Hélène Lehors, Myriam Haddad, Jean-Michel Guys, Rachel Reynaud, Pierre Alessandrini, Thierry Merrot, Kathy Wagner, Jean-Yves Kurzenne, Florence Bastiani, Jean Bréaud, Jean-Stéphane Valla, Gérard Morisson Lacombe, Eric Dobremez, Amel Zahhaf, Jean-Pierre Daures, Charles Sultan
JournalEuropean urology (Eur Urol) Vol. 68 Issue 6 Pg. 1023-30 (Dec 2015) ISSN: 1873-7560 [Electronic] Switzerland
PMID26007639 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Endocrine Disruptors
Topics
  • Child
  • Child, Preschool
  • Endocrine Disruptors (adverse effects)
  • Environmental Exposure (adverse effects)
  • Female
  • France
  • Humans
  • Hypospadias (chemically induced)
  • Infant
  • Infant, Newborn
  • Male
  • Occupational Exposure (adverse effects)
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: